JP2005500354A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500354A5 JP2005500354A5 JP2003517052A JP2003517052A JP2005500354A5 JP 2005500354 A5 JP2005500354 A5 JP 2005500354A5 JP 2003517052 A JP2003517052 A JP 2003517052A JP 2003517052 A JP2003517052 A JP 2003517052A JP 2005500354 A5 JP2005500354 A5 JP 2005500354A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- treatment
- disease
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 201000010099 disease Diseases 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- -1 3,5-bis-trifluoromethyl-phenyl Chemical group 0.000 claims 3
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 claims 3
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 claims 3
- 206010047700 Vomiting Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 206010002855 Anxiety Diseases 0.000 claims 2
- 206010057666 Anxiety disease Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 210000004556 Brain Anatomy 0.000 claims 1
- 206010011401 Crohn's disease Diseases 0.000 claims 1
- 206010013754 Drug withdrawal syndrome Diseases 0.000 claims 1
- 206010019233 Headache Diseases 0.000 claims 1
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010027599 Migraine Diseases 0.000 claims 1
- 208000008085 Migraine Disorders Diseases 0.000 claims 1
- SNICXCGAKADSCV-JTQLQIEISA-N Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- 229960002715 Nicotine Drugs 0.000 claims 1
- 239000012425 OXONE® Substances 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010061536 Parkinson's disease Diseases 0.000 claims 1
- 208000002094 Psychophysiologic Disorders Diseases 0.000 claims 1
- 206010061920 Psychotic disease Diseases 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 201000003152 motion sickness Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 229930015196 nicotine Natural products 0.000 claims 1
- HJKYXKSLRZKNSI-UHFFFAOYSA-I pentapotassium;hydrogen sulfate;oxido sulfate;sulfuric acid Chemical compound [K+].[K+].[K+].[K+].[K+].OS([O-])(=O)=O.[O-]S([O-])(=O)=O.OS(=O)(=O)O[O-].OS(=O)(=O)O[O-] HJKYXKSLRZKNSI-UHFFFAOYSA-I 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000472 traumatic Effects 0.000 claims 1
Claims (12)
- 化合物が、
2−(3,5−ビス−トリフルオロメチル−フェニル)−N−〔6−(1,1−ジオキソ−1λ6−チオモルホリン−4−イル)−4−o−トリル−ピリジン−3−イル〕−N−メチル−イソブチルアミドである、請求項1記載の化合物。 - 化合物が、
2−(3,5−ビス−トリフルオロメチル−フェニル)−N−〔6−(1,1−ジオキソ−1λ6−チオモルホリン−4−イル)−4−(4−フルオロ−2−メチル−フェニル)−ピリジン−3−イル〕−N−メチル−イソブチルアミドである、請求項1記載の化合物。 - 請求項2及び3記載の式Iの化合物、並びに薬学的に許容されうる賦形剤を含む薬剤。
- NK−1レセプターに関連する疾患の処置のための請求項4記載の薬剤。
- 請求項6記載の方法又は同等な方法により調製される、請求項1、2又は3のいずれか1項記載の式Iの化合物
- 疾患の処置における請求項1〜3記載の式Iの化合物の使用。
- NK−1レセプターに関連する疾患の処置における請求項7記載の式Iの化合物の使用。
- NK−1レセプターに関連する疾患の処置のための薬剤の製造における請求項1〜3のいずれか1項記載の式Iの化合物の使用。
- 片頭痛、慢性関節リウマチ、喘息、気管支機能亢進、炎症性腸疾患の処置、あるいはパーキンソン病、不安、抑うつ、疼痛、頭痛、アルツハイマー病、多発性硬化症、浮腫、アレルギー性鼻炎、クローン病、目の損傷、目の炎症性疾患、精神病、乗物酔い、誘導される嘔吐、嘔吐、尿失禁、精神免疫学的若しくは精神身体的障害、癌、アヘン若しくはニコチンの習慣性薬物による禁断症状、外傷性脳障害又は良性前立腺肥大症を含む障害の処置のための薬剤の製造における、請求項10記載の請求項1〜3のいずれか1項記載の式Iの化合物の使用。
- 抑うつ、不安又は嘔吐を処置する薬剤の製造における請求項10及び11記載の式Iの化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01118412 | 2001-07-31 | ||
EP01118412.4 | 2001-07-31 | ||
PCT/EP2002/008311 WO2003011860A2 (en) | 2001-07-31 | 2002-07-26 | 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005500354A JP2005500354A (ja) | 2005-01-06 |
JP2005500354A5 true JP2005500354A5 (ja) | 2005-11-17 |
JP4700908B2 JP4700908B2 (ja) | 2011-06-15 |
Family
ID=8178193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003517052A Expired - Fee Related JP4700908B2 (ja) | 2001-07-31 | 2002-07-26 | 2−(3,5−ビス−トリフルオロメチル−フェニル)−N−〔6−(1,1−ジオキソ−1λ6−チオモルホリン−4−イル)−4−(2−メチル又は4−フルオロ−2−メチル置換)フェニル−ピリジン−3−イル〕−N−メチル−イソブチルアミド |
Country Status (30)
Country | Link |
---|---|
US (1) | US6849624B2 (ja) |
EP (1) | EP1414525B1 (ja) |
JP (1) | JP4700908B2 (ja) |
KR (1) | KR100577101B1 (ja) |
CN (1) | CN1289497C (ja) |
AR (1) | AR034921A1 (ja) |
AT (1) | ATE430600T1 (ja) |
BR (1) | BR0211523A (ja) |
CA (1) | CA2452502C (ja) |
DE (1) | DE60232246D1 (ja) |
EA (1) | EA006238B1 (ja) |
EC (1) | ECSP044963A (ja) |
ES (1) | ES2324209T3 (ja) |
GT (1) | GT200200159A (ja) |
HK (1) | HK1069136A1 (ja) |
HR (1) | HRP20040039A2 (ja) |
HU (1) | HUP0400398A3 (ja) |
MA (1) | MA27055A1 (ja) |
MX (1) | MXPA04000917A (ja) |
MY (1) | MY128464A (ja) |
NO (1) | NO20040404L (ja) |
NZ (1) | NZ530579A (ja) |
PA (1) | PA8551601A1 (ja) |
PE (1) | PE20030276A1 (ja) |
PL (1) | PL366986A1 (ja) |
UA (1) | UA77685C2 (ja) |
UY (1) | UY27403A1 (ja) |
WO (1) | WO2003011860A2 (ja) |
YU (1) | YU2704A (ja) |
ZA (1) | ZA200400652B (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0209151A (pt) * | 2001-04-23 | 2004-07-13 | Hoffmann La Roche | Uso de antagonistas de receptor nk-1 contra hiperplasia prostática benigna |
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
ATE359075T1 (de) | 2002-12-20 | 2007-05-15 | Niconovum Ab | Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose |
CA2514037C (en) * | 2003-01-31 | 2012-03-13 | F. Hoffmann-La Roche Ag | Crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide |
MX2007000198A (es) | 2004-07-06 | 2007-03-15 | Hoffmann La Roche | Proceso para la preparacion de derivados de carboxamida-piridina utilizados como intermediarios en la sintesis de antagonistas del receptor nk-1. |
BRPI0606843A2 (pt) * | 2005-02-22 | 2009-07-21 | Hoffmann La Roche | antagonistas de nk 1 |
WO2006089674A2 (en) | 2005-02-25 | 2006-08-31 | F.Hoffmann-La Roche Ag | Tablets with improved drug substance dispersibility |
EP1998748B1 (en) | 2006-03-16 | 2015-01-14 | NicoNovum AB | Improved snuff composition |
GB0808747D0 (en) | 2008-05-14 | 2008-06-18 | Glaxo Wellcome Mfg Pte Ltd | Novel compounds |
US10383894B2 (en) * | 2010-03-17 | 2019-08-20 | Lutran Industries, Inc. | Human medicinal treatment using salt of peroxymonosulfuric acid |
JP5806420B1 (ja) | 2013-11-08 | 2015-11-10 | キッセイ薬品工業株式会社 | カルボキシメチルピペリジン誘導体 |
TWI649307B (zh) | 2014-05-07 | 2019-02-01 | 日商橘生藥品工業股份有限公司 | Cyclohexylpyridine derivative |
KR20170122777A (ko) | 2015-03-04 | 2017-11-06 | 반다 파마슈티칼즈, 인코퍼레이티드. | 트라디피턴트에 의한 치료 방법 |
CA3101210A1 (en) * | 2018-06-08 | 2019-12-12 | Vanda Pharmaceuticals Inc. | Method of treatment with tradipitant |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6435115A (en) * | 1987-07-31 | 1989-02-06 | Nippon Seiko Kk | Bearing device |
IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
NZ277839A (en) | 1993-12-29 | 1998-01-26 | Merck Sharp & Dohme | Substituted morpholine derivatives, preparation and pharmaceutical compositions thereof |
IL112778A0 (en) | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
US5972938A (en) | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
PT1394150E (pt) | 1999-02-24 | 2011-02-17 | Hoffmann La Roche | Derivados de 4-fenilpiridina e a sua utilização como antagonistas dos receptores de nc-1 |
BR0209151A (pt) * | 2001-04-23 | 2004-07-13 | Hoffmann La Roche | Uso de antagonistas de receptor nk-1 contra hiperplasia prostática benigna |
-
2002
- 2002-07-17 US US10/196,795 patent/US6849624B2/en not_active Expired - Fee Related
- 2002-07-25 PE PE2002000667A patent/PE20030276A1/es not_active Application Discontinuation
- 2002-07-26 NZ NZ530579A patent/NZ530579A/en unknown
- 2002-07-26 EP EP02791471A patent/EP1414525B1/en not_active Expired - Lifetime
- 2002-07-26 ES ES02791471T patent/ES2324209T3/es not_active Expired - Lifetime
- 2002-07-26 AT AT02791471T patent/ATE430600T1/de active
- 2002-07-26 EA EA200400109A patent/EA006238B1/ru not_active IP Right Cessation
- 2002-07-26 JP JP2003517052A patent/JP4700908B2/ja not_active Expired - Fee Related
- 2002-07-26 KR KR1020047001322A patent/KR100577101B1/ko not_active IP Right Cessation
- 2002-07-26 MX MXPA04000917A patent/MXPA04000917A/es active IP Right Grant
- 2002-07-26 HU HU0400398A patent/HUP0400398A3/hu unknown
- 2002-07-26 CA CA2452502A patent/CA2452502C/en not_active Expired - Fee Related
- 2002-07-26 CN CNB028151100A patent/CN1289497C/zh not_active Expired - Fee Related
- 2002-07-26 YU YU2704A patent/YU2704A/sh unknown
- 2002-07-26 PA PA20028551601A patent/PA8551601A1/es unknown
- 2002-07-26 DE DE60232246T patent/DE60232246D1/de not_active Expired - Lifetime
- 2002-07-26 PL PL02366986A patent/PL366986A1/xx not_active Application Discontinuation
- 2002-07-26 UA UA2004021462A patent/UA77685C2/uk unknown
- 2002-07-26 WO PCT/EP2002/008311 patent/WO2003011860A2/en active IP Right Grant
- 2002-07-26 BR BR0211523-9A patent/BR0211523A/pt not_active Application Discontinuation
- 2002-07-29 MY MYPI20022848A patent/MY128464A/en unknown
- 2002-07-29 AR ARP020102847A patent/AR034921A1/es not_active Application Discontinuation
- 2002-07-30 UY UY27403A patent/UY27403A1/es not_active Application Discontinuation
- 2002-07-31 GT GT200200159A patent/GT200200159A/es unknown
-
2004
- 2004-01-15 HR HR20040039A patent/HRP20040039A2/hr not_active Application Discontinuation
- 2004-01-27 ZA ZA200400652A patent/ZA200400652B/xx unknown
- 2004-01-29 NO NO20040404A patent/NO20040404L/no unknown
- 2004-01-29 EC EC2004004963A patent/ECSP044963A/es unknown
- 2004-01-30 MA MA27507A patent/MA27055A1/fr unknown
-
2005
- 2005-02-28 HK HK05101662A patent/HK1069136A1/xx not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005500354A5 (ja) | ||
JP4742026B2 (ja) | ロフルミラストの新規の製造方法 | |
JP4053877B2 (ja) | 4−フェニル−ピリジン誘導体 | |
CA2452502A1 (en) | 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide | |
JP2004504400A5 (ja) | ||
CA2516370A1 (en) | A process of preparing imatinib and imatinib prepared thereby | |
HUP0401201A2 (hu) | Flibanserin stabil polimorfja, ipari eljárás előállítására és alkalmazása gyógyszerek előállítására | |
JP2017533968A5 (ja) | ||
CA2438991A1 (en) | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | |
MXPA04005444A (es) | Ureas de 2-aminobenzotiazoles como moduladores de adenosina. | |
JP2017524005A5 (ja) | ||
JP2004534816A5 (ja) | ||
CY1107411T1 (el) | Θεραπευτικα παραγωγα πιπεραζινης χρησιμα για την αγωγη του πονου | |
JP2002537379A (ja) | フェニルおよびピリジニル誘導体 | |
JP2009510044A5 (ja) | ||
JP2002537382A (ja) | 3−フェニルピリジン誘導体、およびそのnk−1受容体拮抗薬としての用途 | |
CA2540768A1 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
JPWO2019160057A5 (ja) | ||
CA2326529A1 (en) | 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide | |
JP2004504308A5 (ja) | ||
JP2009500292A (ja) | 4−アリル−ニコチンアミド誘導体の製造方法 | |
JP2003529597A5 (ja) | ||
RU2007134901A (ru) | Метаболиты антагонистов nk-1 против рвоты | |
JP2005513004A5 (ja) | ||
JPWO2008029924A1 (ja) | 環状アミノアルキルカルボキサミド誘導体 |